Form 4: C4 Therapeutics Executive Reports Stock Transaction
Insider Transaction (Form 4)
Leonard Reyno, Chief Medical Officer of C4 Therapeutics, Inc., reported multiple transactions in common stock on July 10, 2026.
Summary
- Option exercise/conversion: acquired 15,325 Common Stock on July 10, 2026; holds 379,803 after (Direct).
- Tax/exercise-price withholding: disposed of 7,397 Common Stock at $4.06 ($30,032) on July 10, 2026; holds 372,406 after (Direct).
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as routine: the reported changes are grants, option exercises, tax withholding or similar administrative transactions, which carry limited directional signal.
Insider Transactions
Leonard Reyno — Officer (Chief Medical Officer)
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-10 | Option exercise/conversion | Common Stock | 15,325 | — | — | 379,803 |
| 2026-07-10 | Tax/exercise-price withholding | Common Stock | 7,397 | $4 | $30.0K | 372,406 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-10 | Option exercise/conversion (15,325 shares) |
| 2026-07-10 | Tax/exercise-price withholding (7,397 shares) |
Keywords
insider transaction, Form 4, CCCC, C4 Therapeutics, Inc., neutral, Leonard Reyno
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.